Data completeness
2/8 — Basic
EFAVIRENZ (efavirenz) by Matrix Surgical USA is efavirenz, emtricitabine and tenofovir disoproxil fumarate is a fixed-dose combination of antiviral drugs efv, ftc, and tdf [see ].
Drug data last refreshed 12h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Efavirenz is a fixed-dose combination tablet containing three antiretroviral agents (efavirenz, emtricitabine, and tenofovir disoproxil fumarate) used to treat HIV infection. It works by inhibiting reverse transcriptase and blocking viral replication. This combination regimen is designed to simplify dosing for HIV patients by delivering three active ingredients in a single tablet.
PRE_LAUNCH
Pre-launch stage indicates team building and commercialization planning; early-career professionals may find opportunities in launch strategy and market access roles.
Mechanism of Action
Efavirenz, emtricitabine and tenofovir disoproxil fumarate is a fixed-dose combination of antiviral drugs EFV, FTC, and TDF [see ].
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Started Dec 2026
80 enrolled
Healthy Adult Subject
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants
Started May 2026
18 enrolled
Pain
A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)
Started Feb 2025
34 enrolled
Healthy
A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)
Started Jul 2023
16 enrolled
Healthy
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz
Started Apr 2022
14 enrolled
Malaria
Worked on EFAVIRENZ at Matrix Surgical USA? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.